发明名称 |
Galenic formulations of organic compounds |
摘要 |
The present invention relates to a solid oral dosage form comprising a therapeutically effective amount of aliskiren or a pharmaceutically acceptable salt thereof, and wherein the active ingredient is present in an amount of more than 46% by weight based on the total weight of the oral dosage form.
|
申请公布号 |
US7683054(B2) |
申请公布日期 |
2010.03.23 |
申请号 |
US20050119273 |
申请日期 |
2005.04.29 |
申请人 |
NOVARTIS AG |
发明人 |
RIGASSI-DIETRICH PETRA GISELA;SCHMID MARTIN |
分类号 |
A61K31/54;A61K9/20;A61K9/28;A61K31/00;A61K31/165;A61K31/4166 |
主分类号 |
A61K31/54 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|